DiscoverPTCE Pharmacy Connect | Pharmacy TimesSetting the Scene in Myelofibrosis Treatment and Management | PTCE Pharmacy Connect
Setting the Scene in Myelofibrosis Treatment and Management | PTCE Pharmacy Connect

Setting the Scene in Myelofibrosis Treatment and Management | PTCE Pharmacy Connect

Update: 2022-08-29
Share

Description

Educational Objective: Review the etiology and pathophysiology of myelofibrosis, including the World Health Organization classification and diagnostic criteria.
 
 
Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Hematology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan

 
Victoria Nachar, PharmD, BCOP, has no financial relationships with commercial interests to disclose.



Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-381-H01-P. The activity is available for CE credit through August 29, 2023.

This activity is supported by an educational grant from Incyte Corporation.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Setting the Scene in Myelofibrosis Treatment and Management | PTCE Pharmacy Connect

Setting the Scene in Myelofibrosis Treatment and Management | PTCE Pharmacy Connect

Pharmacy Times